• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study.捷克共和国、挪威和丹麦的阿片类药物维持治疗:一项比较登记关联研究的研究方案。
BMJ Open. 2021 May 10;11(5):e047028. doi: 10.1136/bmjopen-2020-047028.
2
Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway.产前暴露于阿片类药物维持治疗与新生儿结局:来自捷克共和国和挪威的全国登记研究。
Pharmacol Res Perspect. 2019 Aug 14;7(5):e00501. doi: 10.1002/prp2.501. eCollection 2019 Oct.
3
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study.多场所治疗阿片类药物使用障碍患者的病因特异性死亡率:一项前瞻性对照队列研究。
Eur Addict Res. 2023;29(4):272-284. doi: 10.1159/000530822. Epub 2023 Jun 29.
4
Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.孕期接受阿片类药物维持治疗的儿童在产前暴露后的住院情况:来自捷克共和国的全国登记研究。
Addiction. 2019 Jul;114(7):1225-1235. doi: 10.1111/add.14576. Epub 2019 Mar 12.
5
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway.探索阿片类激动剂治疗患者中的双重诊断问题:捷克和挪威的注册链接研究。
Addict Sci Clin Pract. 2024 May 14;19(1):37. doi: 10.1186/s13722-024-00467-5.
6
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.胎儿暴露于美沙酮和丁丙诺啡后的新生儿结局:来自捷克共和国和挪威的国家登记研究。
Addiction. 2018 Jul;113(7):1286-1294. doi: 10.1111/add.14192. Epub 2018 Mar 24.
7
Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study.在不同环境中,超过 13000 名阿片类药物维持治疗患者和非治疗患者的全因和过量死亡率存在很大差异:一项比较登记关联研究。
Front Public Health. 2023 Sep 22;11:1179763. doi: 10.3389/fpubh.2023.1179763. eCollection 2023.
8
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway.阿片类激动剂治疗患者身体发病率的性别差异:来自捷克共和国和挪威的基于人群的队列研究。
Subst Abuse Treat Prev Policy. 2023 Jul 28;18(1):47. doi: 10.1186/s13011-023-00557-8.
9
Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.在阿片类药物维持治疗(OMT)患者中受影响下驾驶(DUI):一项基于登记的全国队列研究。
Addiction. 2013 Nov;108(11):1954-61. doi: 10.1111/add.12275. Epub 2013 Jul 19.
10
Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study.阿片类药物维持治疗(OMT)患者中与退出治疗相关的因素及重新进入治疗的预测因素。一项基于全国登记系统的研究。
Addict Behav. 2014 Oct;39(10):1504-9. doi: 10.1016/j.addbeh.2014.05.007. Epub 2014 May 28.

引用本文的文献

1
Impact of opioid abuse on oral health: a retrospective cohort study.阿片类药物滥用对口腔健康的影响:一项回顾性队列研究。
Front Oral Health. 2025 Feb 21;6:1483406. doi: 10.3389/froh.2025.1483406. eCollection 2025.
2
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway.探索阿片类激动剂治疗患者中的双重诊断问题:捷克和挪威的注册链接研究。
Addict Sci Clin Pract. 2024 May 14;19(1):37. doi: 10.1186/s13722-024-00467-5.
3
Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study.挪威海洛因辅助治疗评估:混合方法研究方案。
BMC Health Serv Res. 2024 Mar 29;24(1):398. doi: 10.1186/s12913-024-10767-w.
4
Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study.在不同环境中,超过 13000 名阿片类药物维持治疗患者和非治疗患者的全因和过量死亡率存在很大差异:一项比较登记关联研究。
Front Public Health. 2023 Sep 22;11:1179763. doi: 10.3389/fpubh.2023.1179763. eCollection 2023.
5
Gender differences in physical morbidity in opioid agonist treatment patients: population-based cohort studies from the Czech Republic and Norway.阿片类激动剂治疗患者身体发病率的性别差异:来自捷克共和国和挪威的基于人群的队列研究。
Subst Abuse Treat Prev Policy. 2023 Jul 28;18(1):47. doi: 10.1186/s13011-023-00557-8.
6
Cause-Specific Mortality among Patients in Treatment for Opioid Use Disorder in Multiple Settings: A Prospective Comparative Cohort Study.多场所治疗阿片类药物使用障碍患者的病因特异性死亡率:一项前瞻性对照队列研究。
Eur Addict Res. 2023;29(4):272-284. doi: 10.1159/000530822. Epub 2023 Jun 29.
7
PriSUD-Nordic-Diagnosing and Treating Substance Use Disorders in the Prison Population: Protocol for a Mixed Methods Study.北欧监狱人群物质使用障碍的诊断与治疗:一项混合方法研究的方案
JMIR Res Protoc. 2022 Mar 23;11(3):e35182. doi: 10.2196/35182.

本文引用的文献

1
Retention in the Austrian opioid agonist treatment system: a national prospective cohort study.奥地利阿片类激动剂治疗系统中的保留率:一项全国前瞻性队列研究。
Harm Reduct J. 2021 Feb 24;18(1):25. doi: 10.1186/s12954-021-00473-9.
2
The Mortality After Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis.监禁释放后死亡率联盟(MARIC):一项多国个体参与者数据荟萃分析的方案
Int J Popul Data Sci. 2020 Jan 25;5(1):1145. doi: 10.23889/ijpds.v5i1.1145.
3
In utero opioid exposure and risk of infections in childhood: A multinational Nordic cohort study.子宫内阿片类药物暴露与儿童感染风险:一项北欧多国队列研究。
Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1596-1604. doi: 10.1002/pds.5088. Epub 2020 Aug 7.
4
Socioeconomic characteristics of women with substance use disorder during pregnancy and neonatal outcomes in their newborns: A national registry study from the Czech Republic.孕期物质使用障碍女性的社会经济特征及其新生儿的新生儿结局:来自捷克共和国的全国登记研究。
Drug Alcohol Depend. 2020 Apr 1;209:107933. doi: 10.1016/j.drugalcdep.2020.107933. Epub 2020 Feb 20.
5
Global patterns of opioid use and dependence: harms to populations, interventions, and future action.全球阿片类药物使用和依赖模式:对人群的危害、干预措施和未来行动。
Lancet. 2019 Oct 26;394(10208):1560-1579. doi: 10.1016/S0140-6736(19)32229-9. Epub 2019 Oct 23.
6
From restrictive to more liberal: variations in moratlity among patients in opioid maintenance treament over a 12-year period.从限制到更自由:12 年间阿片类药物维持治疗患者死亡率的变化。
BMC Health Serv Res. 2019 Aug 7;19(1):553. doi: 10.1186/s12913-019-4382-9.
7
Comparison of psychiatric comorbidity in treatment-seeking, opioid-dependent patients with versus without chronic pain.治疗性寻求、阿片类药物依赖的患者伴发与不伴发慢性疼痛的精神共病比较。
Addiction. 2020 Feb;115(2):249-258. doi: 10.1111/add.14768. Epub 2019 Sep 4.
8
Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.孕期接受阿片类药物维持治疗的儿童在产前暴露后的住院情况:来自捷克共和国的全国登记研究。
Addiction. 2019 Jul;114(7):1225-1235. doi: 10.1111/add.14576. Epub 2019 Mar 12.
9
The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.阿片类激动剂治疗的可及性与阿片类药物滥用之间的复杂关系:以捷克大规模滥用丁丙诺啡为例。
Harm Reduct J. 2018 Dec 4;15(1):60. doi: 10.1186/s12954-018-0268-0.
10
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家层面 195 个国家和地区 1990 年至 2017 年 354 种疾病和伤害导致的发病率、患病率和伤残损失寿命年:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1789-1858. doi: 10.1016/S0140-6736(18)32279-7. Epub 2018 Nov 8.

捷克共和国、挪威和丹麦的阿片类药物维持治疗:一项比较登记关联研究的研究方案。

Opioid maintenance treatment in the Czech Republic, Norway and Denmark: a study protocol of a comparative registry linkage study.

机构信息

Department of Addictology, First Faculty of Medicine, Charles University, Prague, Czech Republic

Department of Addictology, General University Hospital in Prague, Prague, Czech Republic.

出版信息

BMJ Open. 2021 May 10;11(5):e047028. doi: 10.1136/bmjopen-2020-047028.

DOI:10.1136/bmjopen-2020-047028
PMID:33972343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8112418/
Abstract

INTRODUCTION

Opioid maintenance treatment (OMT) varies across settings and between countries. We plan to use data from several nationwide health and population registers to further improve the knowledge base established from earlier studies. Our aim is to study OMT adherence trajectories and to identify factors associated with improved outcomes for OMT patients across the Czech Republic, Norway and Denmark, in order to further improve OMT and our understanding of the key elements of treatment success.

METHODS AND ANALYSIS

The registry-based cohort approach across the three countries allows us to link data from a range of registers on the individual level, by using personal identifiers in nationwide cohorts of OMT and non-OMT patients and the general non-using populations. A total of ~21 500 OMT patients over the last two decades in all three countries will be included in the study. The following outcome variables (based on the International Classification of Diseases, 10th Revision codes) will be obtained from relevant registers: treatment adherence to OMT, comorbidity (somatic and mental health), and all-cause and cause-specific mortality. Outcomes of the country-specific analyses will be pooled.

ETHICS AND DISSEMINATION

The national OMT cohorts have been approved by the ethics committees in the respective countries. Data will be stored according to national and local guidelines and treated confidentially, and all data will be analysed separately for each country and compared across countries. Findings will be disseminated in peer-reviewed scientific journals, national and international conferences, and in briefings to inform clinical decision-making.

摘要

介绍

阿片类药物维持治疗(OMT)在不同的环境和国家之间存在差异。我们计划利用来自多个全国性健康和人口登记处的数据,进一步改进从早期研究中建立的知识库。我们的目的是研究 OMT 依从性轨迹,并确定与捷克共和国、挪威和丹麦的 OMT 患者改善结果相关的因素,以进一步改善 OMT 并加深我们对治疗成功关键要素的理解。

方法和分析

在这三个国家的基于登记的队列研究方法使我们能够通过在全国性 OMT 和非 OMT 患者以及一般非使用者群体的队列中使用个人标识符,在个体层面上链接来自一系列登记处的数据。将在过去二十年中总共纳入来自所有三个国家的约 21500 名 OMT 患者。将从相关登记处获得以下结局变量(基于国际疾病分类,第 10 次修订版代码):对 OMT 的治疗依从性、合并症(躯体和心理健康)以及全因和病因特异性死亡率。将对各国特定分析的结果进行汇总。

伦理和传播

国家 OMT 队列已获得各自国家伦理委员会的批准。将根据国家和地方指南存储数据,并对其进行保密处理,并且将分别对每个国家进行数据分析,并在国家之间进行比较。研究结果将在同行评议的科学期刊、国家和国际会议以及简报中传播,以告知临床决策。